Schedule 13G ownership disclosure

CELLECT BIOTECHNOLOGY LTD

Security class unavailable · CUSIP: 15116C102

Event date: 2016-07-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-025622
Form type
SC 13G
Filer
Askenasy Nadir
CIK
CIK 1702350
Filed
May 09, 2017
Reporting period
Jul 28, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub